Hepion Pharmaceuticals, Inc.
HEPA
$0.0641
-$0.0015-2.29%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 38.27% | -65.00% | -97.25% | -92.24% | -93.07% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -53.05% | -25.49% | -55.32% | -27.81% | 50.28% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -17.82% | -59.05% | -90.77% | -83.40% | -83.27% |
|
|||||
Total Current Assets | -17.82% | -59.05% | -90.77% | -83.40% | -83.27% |
Net Property, Plant & Equipment | -- | -- | -100.00% | -58.29% | 147.86% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -74.43% | -22.89% |
Total Assets | -25.04% | -60.48% | -91.08% | -85.14% | -83.53% |
|
|||||
Total Accounts Payable | -61.32% | -83.75% | -90.63% | -93.80% | -89.35% |
Total Accrued Expenses | -87.07% | -79.02% | -98.64% | -89.48% | -87.94% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | 5.08% | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -39.23% | -63.64% | -40.57% | -57.58% | -87.29% |
|
|||||
Total Current Liabilities | -39.23% | -63.64% | -40.57% | -57.58% | -87.29% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -92.14% | -74.60% | -93.86% | -39.21% | -40.02% |
Total Liabilities | -71.06% | -71.39% | -67.85% | -53.40% | -75.83% |
|
|||||
Common Stock & APIC | 5.89% | 5.50% | 1.72% | 2.67% | 2.42% |
Retained Earnings | -5.86% | -7.23% | -5.87% | -10.63% | -13.97% |
Treasury Stock & Other | 115.43% | -9.78% | 110.53% | 42.71% | 38.65% |
Total Common Equity | 12.59% | -62.22% | -163.71% | -114.53% | -92.44% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | 12.59% | -62.22% | -163.71% | -114.53% | -92.44% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 6.60% | -48.20% | -125.59% | -102.52% | -86.49% |
|